202 related articles for article (PubMed ID: 37644458)
21. SARS-CoV-2 Disease Severity and Cycle Threshold Values in Children Infected during Pre-Delta, Delta, and Omicron Periods, Colorado, USA, 2021-2022.
Bankers L; O'Brien SC; Tapay DM; Ho E; Armistead I; Burakoff A; Dominguez SR; Matzinger SR
Emerg Infect Dis; 2024 Jun; 30(6):1182-1192. PubMed ID: 38781929
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service.
Radhakrishnan N; Liu M; Idowu B; Bansari A; Rathi K; Magar S; Mundhra L; Sarmiento J; Ghaffar U; Kattan J; Jones R; George J; Yang Y; Southwick F
BMC Infect Dis; 2023 Oct; 23(1):747. PubMed ID: 37907849
[TBL] [Abstract][Full Text] [Related]
23. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Petrone D; Mateo-Urdiales A; Sacco C; Riccardo F; Bella A; Ambrosio L; Lo Presti A; Di Martino A; Ceccarelli E; Del Manso M; Fabiani M; Stefanelli P; Pezzotti P; Palamara A;
Int J Infect Dis; 2023 Apr; 129():135-141. PubMed ID: 36708869
[TBL] [Abstract][Full Text] [Related]
24. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Sensitivity of Saliva and Other Respiratory Tract Samples of SARS-CoV-2 Variants in Patients with COVID-19.
Lawrence Panchali MJ; Kim CM; Lee YM; Seo JW; Kim DY; Yun NR; Kim DM
Microbiol Spectr; 2023 Mar; 11(2):e0307622. PubMed ID: 36976007
[TBL] [Abstract][Full Text] [Related]
29. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.
Esper FP; Adhikari TM; Tu ZJ; Cheng YW; El-Haddad K; Farkas DH; Bosler D; Rhoads D; Procop GW; Ko JS; Jehi L; Li J; Rubin BP
J Infect Dis; 2023 Feb; 227(3):344-352. PubMed ID: 36214810
[TBL] [Abstract][Full Text] [Related]
30. Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review.
Arabi M; Al-Najjar Y; Mhaimeed N; Salameh MA; Paul P; AlAnni J; Abdelati AA; Laswi I; Khanjar B; Al-Ali D; Elshafeey A; Mhaimeed O; Burney Z; D'Souza A; Sinha P; Bhatti M; Pillai KV; Homssi M; Bshesh K; Yagan L; Zakaria D
J Cell Mol Med; 2023 Jun; 27(11):1443-1464. PubMed ID: 37203288
[TBL] [Abstract][Full Text] [Related]
31. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
[TBL] [Abstract][Full Text] [Related]
32. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
[TBL] [Abstract][Full Text] [Related]
33. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.
Buchan SA; Chung H; Brown KA; Austin PC; Fell DB; Gubbay JB; Nasreen S; Schwartz KL; Sundaram ME; Tadrous M; Wilson K; Wilson SE; Kwong JC
JAMA Netw Open; 2022 Sep; 5(9):e2232760. PubMed ID: 36136332
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory Biomarkers Differ among Hospitalized Veterans Infected with Alpha, Delta, and Omicron SARS-CoV-2 Variants.
Park C; Tavakoli-Tabasi S; Sharafkhaneh A; Seligman BJ; Hicken B; Amos CI; Chou A; Razjouyan J
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833680
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.
Sakuramoto K; Wada D; Maruyama S; Muroya T; Saito F; Nakamori Y; Kuwagata Y
BMC Infect Dis; 2024 Feb; 24(1):223. PubMed ID: 38374034
[TBL] [Abstract][Full Text] [Related]
36. Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2.
Ghosh AK; Landt O; Yeasmin M; Sharif M; Ratul RH; Molla MA; Nafisa T; Mosaddeque MB; Hosen N; Bulbul MRH; Mamunur R; Islam A; Shakil SS; Kaiser M; Amin MR; Lytton SD
Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423054
[TBL] [Abstract][Full Text] [Related]
37. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.
Hu FH; Jia YJ; Zhao DY; Fu XL; Zhang WQ; Tang W; Hu SQ; Wu H; Ge MW; Du W; Shen WQ; Zhu B; Chen HL
Clin Microbiol Infect; 2023 Jul; 29(7):835-844. PubMed ID: 36934872
[TBL] [Abstract][Full Text] [Related]
39. Chest CT Findings in Hospitalized Patients with SARS-CoV-2: Delta versus Omicron Variants.
Yoon SH; Lee JH; Kim BN
Radiology; 2023 Jan; 306(1):252-260. PubMed ID: 35762887
[TBL] [Abstract][Full Text] [Related]
40. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron.
Wang L; Berger NA; Kaelber DC; Davis PB; Volkow ND; Xu R
medRxiv; 2022 Jan; ():. PubMed ID: 35018384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
